Celltex Therapeutics Corporation Logo
  • ESPAÑOL
  • Enroll Today
  • Request Information
  • Contact Us
  • Therapy Services
  • Stem Cell Banking
  • The Celltex Difference
  • How It Works
  • Our Science & Lab
  • View Clinical Trials
  • Conditions, Disorders & Diseases
  • Frequently Asked Questions
  • News & Press
  • Client Results
  • Client Stories
  • Client Assessment
  • Attend a Webinar
  • View our Online Webinar
  • View More

Connect

  • Facebook
  • Twitter
  • Instagram
  • LinkedIn
  • Vimeo

Partners

  • Medical Professionals

Legal

  • Privacy Policy
  • Terms & Conditions

© 2025 Celltex Therapeutics Corporation. All rights reserved.

Celltex Therapeutics Corporation Logo Celltex Logo
  • ESPAÑOL
  • Enroll Today
  • Request Information
  • Contact Us
  • Products & Services
    • Therapy
    • Stem Cell Banking
    • The Celltex Difference
  • How It Works
    • How It Works
    • Our Science & Lab
    • Conditions, Disorders & Diseases
  • Results
    • Clinical Trials
    • Client Results
    • Client Stories
  • Resources
    • Stem Cell 101
    • Attend a Webinar
    • View Previous Webinars
    • Request Information
    • Client Assessment
    • Extraction Sites
    • For Physicians
    • Company Information
    • Careers
  • FAQs
  • News

COVID-19 Updates from Celltex Therapeutics

Celltex Seeks to Treat COVID-19 Cases

The COVID-19 pandemic has the global medical profession working around the clock looking for vaccines and therapies. Recent studies have reported that therapy with Mesenchymal Stem Cells (MSCs) facilitated recovery from this highly contagious virus. Learn more about these studies by following our news page.
Learn More

Serving You in Your Time Of Need

In pursuit of your health, during the National Emergency, Celltex is working with the FDA on an Expanded Access protocol associated with its current IND application, to provide your own MSCs banked at Celltex to a licensed physician to administer therapy without having to travel outside the US.

If you currently have your MSCs banked at Celltex and are wondering what options are available to you, please contact the Client Services team today by completing the form on our Request a Consultation page, by calling (713) 590-1000 or sending an email to info@celltexbank.com. If you are not a client but would like to bank you MSCs, please complete our online client assessment and a Client Services Coordinator will contact you.
Complete Client Assessment

COVID-19 Interactive Map

Professor Lauren Gardner, a civil and systems engineering professor at Johns Hopkins University, built the dashboard below with her graduate student, Ensheng Dong. It is maintained at the Center for Systems Science and Engineering at the Whiting School of Engineering, with technical support from ESRI and the Johns Hopkins University Applied Physics Laboratory.

It was developed to provide researchers, public health authorities, and the general public with a user-friendly tool to track the outbreak as it unfolds.

Celltex Therapeutics Office & Lab Precautions

We have been closely monitoring the guidelines set forth from the Centers for Disease Control (CDC) and the World Health Organization (WHO) in response to COVID-19. The safety and health of our team, clients and community is extremely important to us and because of this, we are taking proper precautions in our corporate office and lab environment.

COVID -19 Updates

  • What Conditions Can Stem Cells Be Used For?
    September 10, 2024 8:13 am

    In this article, we explore several conditions and health concerns that stem cells may help mitigate. Beyond the anecdotes and testimonials, research has examined the use of MSC therapy in autoimmune conditions, joint diseases, neurological disorders, and more.

  • Development of COVID‐19 Therapies from Birthing Tissues and Cord Blood
    October 28, 2020 1:48 pm

    Celltex Therapeutics Corporation was mentioned in the Stem Cell Journals publication as one of the five largest stem cell therapy trials using MSCs to fight COVID in an article titled “Development of COVID‐19 Therapies from Birthing Tissues and Cord Blood”.

  • Former U.S. Secretary of Energy and Texas Governor, Rick Perry, Names Two Texas Companies as Leading Innovators in the Fight Against COVID-19
    August 3, 2020 4:11 pm

    Celltex Therapeutics obtains approval from FDA to evaluate Celltex’s Mesenchymal Stem Cells as prevention against COVID-19 and Medistar Corporation’s biodefense HVAC filter to destroy nearly 100% of the virus

  • Could the key to defeating COVID-19 lie within our own cells?
    July 22, 2020 4:55 pm

    The key to defeating and preventing COVID-19 may lie within our own cells, according to a San Antonio doctor who aims to prove that theory with several studies just recently approved by the U.S. Food and Drug Administration.

  • Celltex on Talking with Tony Buzbee KSEV Radio Show
    July 22, 2020 4:45 pm
  • Rick Perry Discusses Celltex’s COVID-19 Clinical Trials on Fox News TV
    June 30, 2020 1:39 pm

    Former U.S. Secretary of Energy and former Governor of Texas, Rick Perry, was on Fox News TV discussing Celltex’s COVID-19 ongoing clinical trials and the ingenuity that will deliver a victory over this virus.

  • Celltex & COVID-19 Clinical Trials
    June 29, 2020 3:06 pm

    Celltex has three ongoing COVID-19 clinical trials using Celltex’s TRUECELL™ Mesenchymal Stem Cells (MSCs), a Phase III and two Phase II.

  • Celltex’s Dr. Derek Guillory on the Erick Erickson Show
    April 6, 2020 10:20 am

    Dr. Derek W. Guillory, Founder and Medical Director of Root Causes Medicine in San Antonio and Principal Investigator for Celltex’s upcoming clinical trial was recently brought on as a guest of the Erick Erickson Show on WSB Radio.

  • Celltex has submitted Emergency Expanded Access Clinical Study for Subjects with Coronavirus 2019 (COVID-19) using multiple dose Infusions of Autologous Adipose-Tissue Derived Mesenchymal Stem Cells (ADMSCs)
    April 2, 2020 1:08 pm

    The COVID-19 pandemic has the global medical profession working around the clock looking for vaccines and therapies. On March 21st, 2020, Celltex submitted an emergency expanded access clinical study to the United States Food and Drug Administration (FDA) that would allow patients with COVID-19 to receive infusions of autologous Adipose-tissue derived Mesenchymal Stem Cells (AdMSCs) in the US.

  • Aging & Disease Reports Transplantation of ACE2- Mesenchymal Stem Cells Improves the Outcome of Patients with COVID-19 Pneumonia
    March 25, 2020 12:06 pm

    The COVID-19 pandemic has the global medical profession working around the clock looking for vaccines and therapies. The journal Aging & Disease has recently reported on a study that has proven transplantation of mesenchymal stem cells has improved the outcome of 7 patients diagnosed with COVID-19 Pneumonia in Bejing, China.

Celltex Logo
  • ESPAÑOL
  • Enroll Today
  • Request Information
  • Contact Us

Connect

  • Facebook
  • Twitter
  • Instagram
  • LinkedIn
  • Vimeo

About

  • Company Information
  • About Celltex
  • Board of Directors
  • Executive Team
  • Client Services Team
  • Celltex Mexico
  • Site Map
  • News & Press
  • Careers

Partners

  • Medical Professionals

Legal

  • Privacy Policy
  • Terms & Conditions

© 2025 Celltex Therapeutics Corporation. All rights reserved.